Roadzen
RDZNNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $1.11 Prior regular-session close from the quote source.
- $1.11–$1.18 Regular-session low and high so far today.
- 150.2K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Nov 13 projected Projected for 2026-11-13 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $0.98–$2.56 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own RDZN if improving operating leverage and revenue growth outpace an ongoing cash burn and negative equity that require external financing.
RDZN price history
Loading recent earnings…
Investment thesis
What must happen next
Adoption of Roadzen's AI-powered auto-insurance products and partner distribution will continue driving year-over-year GAAP revenue growth.StrengtheningMateriality: High
Revenue increased from $13,560,498 (FY2023) to $46,724,287 (FY2024) and then to $55,021,792 (FY2026) — showing the business can grow top line. If revenue keeps scaling from partners and product adoption, fixed platform costs can leverage into profitability; if not, the company will remain a capital-consuming growth story.
Watch: Loss of one or more large distribution partners or a major insurer partner moving to an incumbent or in-house AI solution, which would reduce new business flow.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue increased from $13,560,498 (FY2023) to $46,724,287 (FY2024) and then to $55,021,792 (FY2026) — showing the business can grow top.
Open source ↗Roadzen's product mix yields high gross margins that provide room to invest in growth while protecting pricing power and per-unit economics.StrengtheningMateriality: High
Gross profit (derived) rose to $33,744,213 in FY2026 on $55,021,792 revenue, implying a gross margin in the ~60% range. Sustained high gross margins mean revenue growth can be reinvested in sales/R&D without destroying unit economics; margin compression would force either higher prices or lower growth/dilution.
Watch: Commoditization of AI insurance tooling by larger tech firms or incumbents forcing price competition and compressing margins.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Gross profit (derived) rose to $33,744,213 in FY2026 on $55,021,792 revenue, implying a gross margin in the ~60% range.
Open source ↗Roadzen is demonstrating material operating leverage: fixed platform/R&D costs can be spread over higher revenue so operating losses shrink toward profitability if growth continues.StrengtheningMateriality: Medium
Operating income improved from -$77,658,837 (FY2024) to -$60,812,942 (FY2025) to -$13,997,054 (FY2026), showing a clear narrowing of operating losses. Operating leverage turning fixed costs into profits is the mechanism that converts top-line and product strength into shareholder value; if leverage reverses, value evaporates.
Watch: A strategic decision to reaccelerate hiring or go-to-market spending (e.g., heavy international expansion) that widens operating losses again.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating income improved from -$77,658,837 (FY2024) to -$60,812,942 (FY2025) to -$13,997,054 (FY2026), showing a clear narrowing of operating losses.
Open source ↗Because Roadzen generates negative operating cash flow and has negative shareholders' equity, it will need external financing (equity or debt) to execute growth — raising the risk of dilution or constrained operations.StrengtheningMateriality: Medium
Stockholders' equity is negative and has deteriorated: -$10,073,836 (FY2024) -> -$25,073,897 (FY2025) -> -$29,648,237 (FY2026). If financing is dilutive or unavailable on acceptable terms, growth and margin improvements can be halted; conversely a non-dilutive strategic partner or cash flow turnaround materially de-risks the equity.
Watch: A successful financing (e.g., equity raise or strategic investment) that covers runway without onerous dilution.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Stockholders' equity is negative and has deteriorated: -$10,073,836 (FY2024) -> -$25,073,897 (FY2025) -> -$29,648,237 (FY2026).
Open source ↗A large technical headcount (R&D/ML engineers) is the main input to Roadzen's AI product advantage; maintaining and monetizing that IP is necessary to keep competitors at bay.HoldingMateriality: Medium
Roadzen reports 458 full-time employees as of March 31, 2026, consistent with a sizable product and engineering organization. If headcount and R&D convert into differentiated models and insurer integrations, Roadzen can sustain pricing and win distribution; failure to convert the team into defensible IP means costs without a moat.
Watch: Inability to protect or quickly commercialize AI models (no patents, rapid replication by larger competitors).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Roadzen reports 458 full-time employees as of March 31, 2026, consistent with a sizable product and engineering organization.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Adoption of Roadzen's AI-powered auto-insurance products and partner distribution will continue driving year-over-year GAAP revenue growth. If revenue keeps scaling from partners and product adoption, fixed platform costs can leverage into profitability; if not, the company will remain a capital-consuming growth story.
Roadzen's product mix yields high gross margins that provide room to invest in growth while protecting pricing power and per-unit economics. Sustained high gross margins mean revenue growth can be reinvested in sales/R&D without destroying unit economics; margin compression would force either higher prices or lower growth/dilution.
Roadzen is demonstrating material operating leverage: fixed platform/R&D costs can be spread over higher revenue so operating losses shrink toward profitability if growth continues. Operating leverage turning fixed costs into profits is the mechanism that converts top-line and product strength into shareholder value; if leverage reverses, value evaporates.
Because Roadzen generates negative operating cash flow and has negative shareholders' equity, it will need external financing (equity or debt) to execute growth — raising the risk of dilution or constrained operations. If financing is dilutive or unavailable on acceptable terms, growth and margin improvements can be halted; conversely a non-dilutive strategic partner or cash flow turnaround materially de-risks the equity.
A large technical headcount (R&D/ML engineers) is the main input to Roadzen's AI product advantage; maintaining and monetizing that IP is necessary to keep competitors at bay. If headcount and R&D convert into differentiated models and insurer integrations, Roadzen can sustain pricing and win distribution; failure to convert the team into defensible IP means costs without a moat.
All standing thesis claims
Original report summary
improving operating leverage and revenue growth outpace an ongoing cash burn and negative equity that require external financing.
Bull case and bear case
Bull case and bear case for Roadzen
Where the evidence on Roadzen stands: Holding on the latest evidence (Nov 9, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.
Bull case: what the evidence supports
Adoption of Roadzen's AI-powered auto-insurance products and partner distribution will continue driving year-over-year GAAP revenue growth.
Roadzen's product mix yields high gross margins that provide room to invest in growth while protecting pricing power and per-unit economics.
Roadzen is demonstrating material operating leverage: fixed platform/R&D costs can be spread over higher revenue so operating losses shrink toward profitability if growth continues.
Because Roadzen generates negative operating cash flow and has negative shareholders' equity, it will need external financing (equity or debt) to execute growth — raising the risk of dilution or constrained operations.
A large technical headcount (R&D/ML engineers) is the main input to Roadzen's AI product advantage; maintaining and monetizing that IP is necessary to keep competitors at bay.
Bear case: what would count against it
Loss of one or more large distribution partners or a major insurer partner moving to an incumbent or in-house AI solution, which would reduce new business flow.
Commoditization of AI insurance tooling by larger tech firms or incumbents forcing price competition and compressing margins.
A strategic decision to reaccelerate hiring or go-to-market spending (e.g., heavy international expansion) that widens operating losses again.
Thesis-Break Engine
Thesis-break watch · Roadzen
No break has crossed Roadzen’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedDirector or principal officer change.
Roadzen filed an SEC 8-K on 2026-09-16: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Roadzen filed an SEC 8-K on 2026-08-13: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
Roadzen filed an SEC 8-K on 2026-07-09: Entered a material definitive agreement. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Loss of one or more large distribution partners or a major insurer partner moving to an incumbent or in-house AI solution, which would reduce new business flow.
- Commoditization of AI insurance tooling by larger tech firms or incumbents forcing price competition and compressing margins.
- A strategic decision to reaccelerate hiring or go-to-market spending (e.g., heavy international expansion) that widens operating losses again.
- A successful financing (e.g., equity raise or strategic investment) that covers runway without onerous dilution.
- Inability to protect or quickly commercialize AI models (no patents, rapid replication by larger competitors).
RDZN news
Loading headlines…
Financial statements
RDZN income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
RDZN: quick answers
- When does Roadzen (RDZN) report earnings next?
- Roadzen's next results are projected for November 13, 2026, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on August 13, 2026. Earnings calendar
- What is RDZN's short interest?
- As of October 30, 2026, 2.0M RDZN shares were sold short, 2.34% of its shares outstanding, down 23.6% from the count before. At the stock's average daily volume that is 7.5 days to cover. FINRA publishes the count twice a month. RDZN short interest history